Cernostics, Dutch Medical Center Collaborate on Barrett's Esophagus-related Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – Cernostics said on Tuesday it is collaborating with the Academic Medical Center in the Netherlands to complete validation studies of the company's test for cancer in patients with Barrett's Esophagus.

AMC will provide Cernostics access to its Barrett's Esophagus patient registry, which Cernostics will use to complete studies of its TissueCypher:Barrett's. Under the direction of Jacques Bergman, AMC has identified 5,000 patients from 16 hospitals in the Amsterdam region with the ailment, Cernostics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.